1. Home
  2. AGIO vs DRVN Comparison

AGIO vs DRVN Comparison

Compare AGIO & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$37.57

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$14.31

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
DRVN
Founded
2007
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Automotive Aftermarket
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
AGIO
DRVN
Price
$37.57
$14.31
Analyst Decision
Buy
Buy
Analyst Count
8
8
Target Price
$38.88
$18.33
AVG Volume (30 Days)
1.0M
774.6K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.70
EPS
N/A
0.33
Revenue
$43,011,000.00
$1,862,438,000.00
Revenue This Year
$76.75
N/A
Revenue Next Year
$170.73
$1.53
P/E Ratio
N/A
$41.24
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$9.80
52 Week High
$46.00
$19.74

Technical Indicators

Market Signals
Indicator
AGIO
DRVN
Relative Strength Index (RSI) 52.01 50.73
Support Level $26.71 $14.34
Resistance Level $44.01 $14.47
Average True Range (ATR) 1.69 0.59
MACD -0.77 -0.18
Stochastic Oscillator 27.89 35.12

Price Performance

Historical Comparison
AGIO
DRVN

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

Share on Social Networks: